Physician profile
Madison Lashley
NPI 1598176380
$1,499.10
in general payments reported to CMS, 2019-2025
11 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.15 · 2021: $145 · 2023: $89.02 · 2024: $897 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772 · Travel and Lodging: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.89 |
| Travel and Lodging | $531.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,056.44 | 2021-2025 | Phasix Mesh |
| Haemonetics Corporation | $121.88 | 2025 | Teg6s Hemostasis System |
| Zimmer Biomet Holdings, INC. | $86.31 | 2025 | Ribfix Blu Advantage |
| Solventum Corporation | $80.67 | 2025 | V.A.C. Veraflo |
| Kci USA, INC. | $59.78 | 2023 | V.A.C. Veraflo |
| Acell, INC. | $20.95 | 2019 | |
| Shire North American Group INC | $17.01 | 2019 | |
| Myriad Genetic Laboratories, INC. | $16.24 | 2023 | Myrisk |
| Atricure, INC. | $13.63 | 2024 | |
| Smith+Nephew, INC. | $13.19 | 2019 | |
| Kerecis Limited | $13.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Lashley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.